25 September 2015
A common therapeutic target for the treatment of inflammatory bowel disease (IBD) may actually protect against intestinal inflammation by inhibiting pathogenic T-cells, investigators report.
http://www.sciencedaily.com/releases/2015/09/150925085956.htm
